LP22: The use of blink reflex study in determining the clinical recovery and quality of life in Bell’s palsy patient

oped severe generalized weakness and required mechanical ventilation. At that time, RNST was abnormal in ADQ. Treatment of WM with Rituximab dramatically improved symptoms and led to a progressive and sustained decrease of IgM and anti-MuSK titres. Six years later, patient remains stable without treatment. Discussion: Neurophysiological features studies allowed to rule out a peripheral neuropathy, played a role the diagnosis of MG and, more on, its features correlated with clinical status. Response to rituximab could throw additional light on the role of B cells as therapeutic targets in anti-MuSK positive MG.